{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:25:21Z","timestamp":1707524721412},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,16]]},"DOI":"10.7759\/cureus.28057","type":"journal-article","created":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T12:56:52Z","timestamp":1660654612000},"source":"Crossref","is-referenced-by-count":0,"title":["Rhinocerebral Mucormycosis: An Emerging Threat in the Era of COVID-19"],"prefix":"10.7759","author":[{"given":"Deoda","family":"Maassarani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georges F","family":"Bassil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micheal","family":"Nehme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anis","family":"Nassar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Ghanime","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziad","family":"Sleiman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/jof7040298","article-title":"When uncontrolled diabetes mellitus and severe COVID-19 converge: the perfect storm for mucormycosis","volume":"7","author":"John TM","year":"2021","unstructured":"John TM, Jacob CN, Kontoyiannis DP. When uncontrolled diabetes mellitus and severe COVID-19 converge: the perfect storm for mucormycosis. J Fungi (Basel). 2021, 7:298. 10.3390\/jof7040298","journal-title":"J Fungi (Basel)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-241663","article-title":"COVID-19 triggering mucormycosis in a susceptible patient: a new phenomenon in the developing world?","volume":"14","author":"Revannavar SM","year":"2021","unstructured":"Revannavar SM, Supriya PS, Samaga L, Vineeth VK. COVID-19 triggering mucormycosis in a susceptible patient: a new phenomenon in the developing world?. BMJ Case Rep. 2021, 14:e241663. 10.1136\/bcr-2021-241663","journal-title":"BMJ Case Rep"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/CXO.12618","article-title":"Eyelid, Conjunctival, and Orbital Tumors. An Atlas and Textbook, third edition Jerry A Shields, Carol L Shields Wolters Kluwer 2015, 824 pages, $456.00","volume":"101","author":"Roth M","year":"2018","unstructured":"Roth M. Eyelid, Conjunctival, and Orbital Tumors. An Atlas and Textbook, third edition Jerry A Shields, Carol L Shields Wolters Kluwer 2015, 824 pages, $456.00. Clin Exp Optom. 2018, 101:618-9. 10.1111\/CXO.12618","journal-title":"Clin Exp Optom"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1086\/599105","article-title":"Recent advances in the management of mucormycosis: from bench to bedside","volume":"48","author":"Spellberg B","year":"2009","unstructured":"Spellberg B, Walsh TJ, Kontoyiannis DP, Edwards J Jr, Ibrahim AS. Recent advances in the management of mucormycosis: from bench to bedside. Clin Infect Dis. 2009, 48:1743-51. 10.1086\/599105","journal-title":"Clin Infect Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4103\/ccd.ccd_558_17","article-title":"Mucormycosis in a diabetic patient: a case report with an insight into its pathophysiology","volume":"8","author":"Afroze SN","year":"2017","unstructured":"Afroze SN, Korlepara R, Rao GV, Madala J. Mucormycosis in a diabetic patient: a case report with an insight into its pathophysiology. Contemp Clin Dent. 2017, 8:662-6. 10.4103\/ccd.ccd_558_17","journal-title":"Contemp Clin Dent"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.mycmed.2020.100971","article-title":"Invasive fungal diseases during COVID-19: we should be prepared","volume":"30","author":"Gangneux JP","year":"2020","unstructured":"Gangneux JP, Bougnoux ME, Dannaoui E, Cornet M, Zahar JR. Invasive fungal diseases during COVID-19: we should be prepared. J Mycol Med. 2020, 30:100971. 10.1016\/j.mycmed.2020.100971","journal-title":"J Mycol Med"},{"key":"ref7","article-title":"Studies of opportunistic fungi. I. Inhibition of Rhizopus oryzae by human serum","volume":"241","author":"Gale GR","year":"1961","unstructured":"Gale GR, Welch AM. Studies of opportunistic fungi. I. Inhibition of Rhizopus oryzae by human serum. Am J Med Sci. 1961, 241:604-12.","journal-title":"Am J Med Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/00001432-200412000-00003","article-title":"Zygomycosis (mucormycosis): emerging clinical importance and new treatments","volume":"17","author":"Greenberg RN","year":"2004","unstructured":"Greenberg RN, Scott LJ, Vaughn HH, Ribes JA. Zygomycosis (mucormycosis): emerging clinical importance and new treatments. Curr Opin Infect Dis. 2004, 17:517-25. 10.1097\/00001432-200412000-00003","journal-title":"Curr Opin Infect Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir880","article-title":"A global analysis of mucormycosis in France: the RetroZygo Study (2005-2007)","volume":"54","author":"Lanternier F","year":"2012","unstructured":"Lanternier F, Dannaoui E, Morizot G, et al.. A global analysis of mucormycosis in France: the RetroZygo Study (2005-2007). Clin Infect Dis. 2012, 54:S35-43. 10.1093\/cid\/cir880","journal-title":"Clin Infect Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.10726","article-title":"Rhino-orbital mucormycosis associated with COVID-19","volume":"12","author":"Mehta S","year":"2020","unstructured":"Mehta S, Pandey A. Rhino-orbital mucormycosis associated with COVID-19. Cureus. 2020, 12:e10726. 10.7759\/cureus.10726","journal-title":"Cureus"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.25652","article-title":"Clinical characteristics of 100 patients with COVID-19-associated mucormycosis from a tertiary care center in North India","volume":"14","author":"Kant R","year":"2022","unstructured":"Kant R, Totaganti M, Mohan B, et al.. Clinical characteristics of 100 patients with COVID-19-associated mucormycosis from a tertiary care center in North India. Cureus. 2022, 14:e25652. 10.7759\/cureus.25652","journal-title":"Cureus"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/myc.12958","article-title":"Mucormycosis in South America: a review of 143 reported cases","volume":"62","author":"Nucci M","year":"2019","unstructured":"Nucci M, Engelhardt M, Hamed K. Mucormycosis in South America: a review of 143 reported cases. Mycoses. 2019, 62:730-8. 10.1111\/myc.12958","journal-title":"Mycoses"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1086\/432579","article-title":"Epidemiology and outcome of zygomycosis: a review of 929 reported cases","volume":"41","author":"Roden MM","year":"2005","unstructured":"Roden MM, Zaoutis TE, Buchanan WL, et al.. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005, 41:634-53. 10.1086\/432579","journal-title":"Clin Infect Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2020.09.032","article-title":"Mucormycosis with orbital compartment syndrome in a patient with COVID-19","volume":"42","author":"Werthman-Ehrenreich A","year":"2021","unstructured":"Werthman-Ehrenreich A. Mucormycosis with orbital compartment syndrome in a patient with COVID-19. Am J Emerg Med. 2021, 42:264.e5-8. 10.1016\/j.ajem.2020.09.032","journal-title":"Am J Emerg Med"},{"key":"ref15","article-title":"Rhinocerebral mucormycosis: an update","volume":"14","author":"Mallis A","year":"2010","unstructured":"Mallis A, Mastronikolis SN, Naxakis SS, Papadas AT. Rhinocerebral mucormycosis: an update. Eur Rev Med Pharmacol Sci. 2010, 14:987-92.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1086\/427690","article-title":"Serious infections in elderly patients with diabetes mellitus","volume":"40","author":"Rajagopalan S","year":"2005","unstructured":"Rajagopalan S. Serious infections in elderly patients with diabetes mellitus. Clin Infect Dis. 2005, 40:990-6. 10.1086\/427690","journal-title":"Clin Infect Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2005.10.017","article-title":"Disseminated rhinocerebral mucormycosis: a case report and review of the literature","volume":"64","author":"O'Neill BM","year":"2006","unstructured":"O'Neill BM, Alessi AS, George EB, Piro J. Disseminated rhinocerebral mucormycosis: a case report and review of the literature. J Oral Maxillofac Surg. 2006, 64:326-33. 10.1016\/j.joms.2005.10.017","journal-title":"J Oral Maxillofac Surg"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2009.02999.x","article-title":"Zygomycosis: conventional laboratory diagnosis","volume":"15","author":"Lass-Fl\u00f6rl C","year":"2009","unstructured":"Lass-Fl\u00f6rl C. Zygomycosis: conventional laboratory diagnosis. Clin Microbiol Infect. 2009, 15:60-5. 10.1111\/j.1469-0691.2009.02999.x","journal-title":"Clin Microbiol Infect"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1086\/590004","article-title":"Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis","volume":"47","author":"Chamilos G","year":"2008","unstructured":"Chamilos G, Lewis RE, Kontoyiannis DP. Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. Clin Infect Dis. 2008, 47:503-9. 10.1086\/590004","journal-title":"Clin Infect Dis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myx101","article-title":"Challenges in the diagnosis and treatment of mucormycosis","volume":"56","author":"Skiada A","year":"2018","unstructured":"Skiada A, Lass-Floerl C, Klimko N, Ibrahim A, Roilides E, Petrikkos G. Challenges in the diagnosis and treatment of mucormycosis. Med Mycol. 2018, 56:93-101. 10.1093\/mmy\/myx101","journal-title":"Med Mycol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1086\/589857","article-title":"Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis","volume":"47","author":"Reed C","year":"2008","unstructured":"Reed C, Bryant R, Ibrahim AS, Edwards J Jr, Filler SG, Goldberg R, Spellberg B. Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis. Clin Infect Dis. 2008, 47:364-71. 10.1086\/589857","journal-title":"Clin Infect Dis"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2016.03.029","article-title":"Initial use of combination treatment does not impact survival of 106 patients with haematologic malignancies and mucormycosis: a propensity score analysis","volume":"22","author":"Kyvernitakis A","year":"2016","unstructured":"Kyvernitakis A, Torres HA, Jiang Y, Chamilos G, Lewis RE, Kontoyiannis DP. Initial use of combination treatment does not impact survival of 106 patients with haematologic malignancies and mucormycosis: a propensity score analysis. Clin Microbiol Infect. 2016, 22:811.e1-8. 10.1016\/j.cmi.2016.03.029","journal-title":"Clin Microbiol Infect"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(21)00237-8","article-title":"The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries","volume":"3","author":"Hoenigl M","year":"2022","unstructured":"Hoenigl M, Seidel D, Carvalho A, et al.. The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries. Lancet Microbe. 2022, 3:e543-52. 10.1016\/S2666-5247(21)00237-8","journal-title":"Lancet Microbe"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-009-0109-4","article-title":"Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes","volume":"47","author":"Yang JK","year":"2010","unstructured":"Yang JK, Lin SS, Ji XJ, Guo LM. Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta Diabetol. 2010, 47:193-9. 10.1007\/s00592-009-0109-4","journal-title":"Acta Diabetol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2021.05.019","article-title":"Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India","volume":"15","author":"Singh AK","year":"2021","unstructured":"Singh AK, Singh R, Joshi SR, Misra A. Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India. Diabetes Metab Syndr. 2021, 15:102146. 10.1016\/j.dsx.2021.05.019","journal-title":"Diabetes Metab Syndr"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/99879-rhinocerebral-mucormycosis-an-emerging-threat-in-the-era-of-covid-19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:38:08Z","timestamp":1707507488000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/99879-rhinocerebral-mucormycosis-an-emerging-threat-in-the-era-of-covid-19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,16]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.28057","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8,16]]}}}